Online Advisory
点击这里给我发消息
点击这里给我发消息
 Telephone
+86-571-85335020

MSN:peng001@hotmail.com 
Back Home
Contact us
中文版
Contact us
  • Hangzhou Dawn Ray Pharmaceutical Co.,Ltd
  • Tel:+86-571-85335020
  • Phone:+86-15336875875
  • Fax:+86-571-86948329
  • E-Mail:agnes@dawnraypharma.com
  • Address:1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
  • Home - products List
    Product
     

    Batifiban

    Name:  Batifiban
    CASNO:  
    Usages:  Not only can inhibit integrin receptor alpha IIb beta 3, thereby inhibiting platelet aggregation, an
    Product Introduction

    (Batifiban) is a new generation of platelet glycoprotein receptor GPIIb/IIIa (also known as: integrin receptor alpha IIb beta 3) antagonist, is currently in clinical phase III trial stage. Clinical dosage form for intravenous administration of intravenous administration.
     

    Not only can inhibit integrin receptor alpha IIb beta 3, thereby inhibiting platelet aggregation, and can inhibit the integrin receptor alpha v beta 3, thus inhibiting the growth of vascular smooth muscle, which is also important to prevent the blockage of arterial blood vessel 

    One of the indications for the treatment of the patients with the disease , the treatment of the patients with percutaneous coronary intervention (PCI), and the treatment of the disease.